Analyte sensors and sensing methods featuring low-potential detection
US-2024402120-A1 · Dec 5, 2024 · US
US11852604B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11852604-B2 |
| Application number | US-202016913704-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 26, 2020 |
| Priority date | Jun 26, 2019 |
| Publication date | Dec 26, 2023 |
| Grant date | Dec 26, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
In one embodiment, a system for detecting an analyte in a bodily fluid sample includes an electrochemical biosensor, the electrochemical biosensor configured to receive the bodily fluid sample, test for the analyte, and produce an analyte level for the analyte. The system further includes a mediator, the mediator configured to provide for the testing of the analyte by facilitating electron exchange between the analyte and the biosensor. The system further includes an oxygen tension reducing agent, the oxygen tension reducing agent reducing interference of oxygen with the operation of the mediator.
Opening claim text (preview).
What is claimed as new and desired to be protected by Letters Patent of the United States is: 1. A method of testing for an analyte, with reduced interference of oxygen, the method comprising: providing a system including: an electrochemical biosensor, the electrochemical biosensor configured to receive a bodily fluid sample, test for the analyte, and produce an analyte level for the analyte; a mediator, the mediator configured to provide for the testing of the analyte by facilitating electron exchange between the analyte and the biosensor, wherein the mediator is ferrocyanide and the analyte is hemoglobin; an oxygen tension reducing agent; a meter for receiving the electrochemical biosensor; dosing the electrochemical biosensor with a sample containing the analyte; reducing the interference of oxygen with the operation of the mediator with the oxygen tension reducing agent; detecting an electrical property of the sample with the meter and electrochemical biosensor; and, calculating an analyte level of the analyte with the meter, wherein the oxygen tension reducing agent is laccase. 2. The method of claim 1 , further comprising reducing the interference of oxygen with the oxygen tension reducing agent, wherein the oxygen reducing reagent is laccase. 3. A method of testing for an analyte, with reduced interference of oxygen, the method comprising: providing a system including: an electrochemical biosensor, the electrochemical biosensor configured to receive a bodily fluid sample, test for the analyte, and produce an analyte level for the analyte; a mediator, the mediator configured to provide for the testing of the analyte by facilitating electron exchange between the analyte and the biosensor, wherein the mediator is ferrocyanide and the analyte is hemoglobin; an oxygen tension reducing agent; a meter for receiving the electrochemical biosensor; dosing the electrochemical biosensor with a sample containing the analyte; reducing the interference of oxygen with the operation of the mediator with the oxygen tension reducing agent; detecting an electrical property of the sample with the meter and electrochemical biosensor; and, calculating an analyte level of the analyte with the meter, wherein the oxygen tension reducing agent is a platinum electrode. 4. The method of claim 3 , wherein the reducing includes activating the platinum electrode at oxygen reducing voltage, which causes the platinum electrode to reduce oxygen interference, and then activating the platinum electrode at a detection voltage.
Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels (optical biosensors G01N33/52) · CPC title
Devices therefor, e.g. test element readers, circuitry (details not specific to biochemical electrodes G01N33/4875) · CPC title
Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.